Taevas
United StatesMedical Devices
Imports & Shipments
Imports & Shipments for Medical Devices in United States
Taevas Global helps medical devices manufacturers navigate FDA import requirements, customs clearance, and logistics to successfully bring products into the United States market. From 510(k) readiness to port-of-entry compliance, we deliver the intelligen
Market
United States
Industry
Medical Devices
Service
Imports & Shipments
Regulator
FDA Center for Devices and Radiological Health (CDRH)
Timeline
4-8 weeks
What We Deliver
Six Pillars of United States Medical Devices Intelligence
Our six interconnected pillars give medical devices manufacturers a complete picture of import requirements, market dynamics, and operational readiness needed to enter the United States confidently.
01
FDA Import Regulatory Mapping
We map every FDA requirement applicable to your device class at the point of import, including device listing, establishment registration, and prior notice obligations. Our team translates CDRH guidance into actionable compliance steps tailored to your product category. You receive a clear regulatory roadmap before your first shipment leaves the origin country.
Device classification under 21 CFR Parts 862-892
FDA establishment registration and device listing via FURLS
Prior Notice and import entry requirements under CBP
How It Works
From Brief to Board-Ready Intelligence
Our structured four-step engagement takes medical devices manufacturers from initial intake through a fully validated import and market entry strategy delivered in as little as six weeks.
Step 1 · Day 1-2
Intake and Device Assessment
We begin with a structured intake session to capture your device specifications, intended use, target customer segments, and current regulatory status. Our team reviews existing technical files, predicate device claims, and any prior FDA correspondence. This foundation ensures every subsequent analysis is precisely calibrated to your product and business objectives.
Taevas Approach
The intake process includes completion of our Medical Device Import Readiness Questionnaire, review of existing 510(k) or CE Technical Documentation, and a 90-minute kickoff call with your regulatory and supply chain leads. We also confirm the device's FDA product code and risk classification (Class I, II, or III) to scope the engagement accurately from day one.
Market Snapshot
United States Medical Devices Market at a Glance
$0B
U.S. Medical Device Market Size (2024 est.)
0%
Projected Annual Market Growth Rate
0+
FDA-Registered Device Manufacturers
0+
510(k) Clearances Granted Annually
World's Largest Medical Device Market
The United States represents approximately 40% of global medical device sales, making it the single most important market for any device manufacturer pursuing international growth. The combination of high per-capita healthcare spending, advanced hospital infrastructure, and a large aging population drives sustained demand across all device categories. For importers, this scale means both significant commercial opportunity and intense regulatory scrutiny.
FDA CDRH: A Rigorous but Navigable Regulator
The FDA's Center for Devices and Radiological Health oversees one of the world's most rigorous medical device regulatory frameworks, with mandatory premarket review for most Class II and all Class III devices. The 510(k) pathway remains the primary route for Class II devices, with FDA targeting a 90-day review for standard submissions. Understanding CDRH's current review priorities, refuse-to-accept criteria, and interactive review programs is essential for manufacturers planning their first U.S. import.
Import Refusals Are Preventable
FDA's OASIS system tracked thousands of medical device import refusals in recent years, with the most common reasons being lack of premarket approval, failure to register the establishment, and labeling violations. Many of these refusals could have been prevented with proper pre-import compliance review. A single refused shipment can trigger an automatic detention of all future shipments from the same manufacturer, making pre-entry due diligence a business-critical investment.
UDI and Digital Traceability Requirements
The FDA's Unique Device Identification system now requires virtually all medical devices sold in the United States to carry a UDI on device labels and packaging, with data submitted to the Global Unique Device Identification Database (GUDID). Compliance deadlines have been phased in by device class, and Class I device manufacturers are now fully in scope. For importers, UDI non-compliance at the border results in immediate detention and can delay market entry by months.
What's Included
Everything in Your Report
Each Taevas Global engagement for Imports and Shipments in the United States medical devices market produces eight structured deliverables that together form a complete import and market entry playbook.
FDA Regulatory Pathway Analysis
A device-specific assessment of the applicable FDA premarket pathway (510(k), De Novo, PMA, or exempt) with predicate device identification and a timeline estimate for clearance. Includes risk classification confirmation under 21 CFR.
Import Compliance Checklist
A step-by-step checklist covering FDA establishment registration, device listing, prior notice obligations, and CBP entry documentation requirements specific to your device category. Formatted for use by your customs broker and regulatory team.
HTS Classification and Tariff Report
Validated Harmonized Tariff Schedule classification for your device and key components, with applicable duty rates, Section 301 tariff status, and USMCA or other trade agreement applicability analysis.
Labeling Gap Analysis
A side-by-side comparison of your current device labeling against 21 CFR Part 801 and UDI requirements, with specific remediation recommendations and priority rankings to prevent import refusal.
Port-of-Entry and Logistics Strategy
A comparative analysis of optimal U.S. ports of entry based on FDA district office jurisdiction, freight lanes, cold chain capability, and bonded warehouse availability relevant to your device type.
U.S. Distributor Longlist
A curated longlist of U.S. medical device distributors matched to your device category, target clinical setting, and geographic priorities, with qualification criteria and initial outreach guidance.
Import Alert and Risk Assessment
A review of active FDA Import Alerts applicable to your product category, manufacturer country, or establishment, with a risk assessment and recommended mitigation steps before first shipment.
Reimbursement and Coverage Landscape Brief
An overview of relevant CPT codes, ICD-10 procedure codes, CMS coverage policies, and commercial payer landscape applicable to your device, helping your commercial team frame value propositions for U.S. buyers.
Who This Is For
Built for These Situations
First U.S. Entry
International Manufacturer Entering the U.S. for the First Time
Your device is cleared or approved in your home market and you are ready to pursue the United States, but FDA's import requirements, establishment registration obligations, and customs processes are unfamiliar territory. You need a structured, expert-led roadmap that prevents costly missteps at the border and accelerates your path to first commercial shipment. Taevas Global gives you the compliance foundation and market intelligence to enter with confidence.
Outcome
Achieve first compliant U.S. import shipment within your target timeline with zero border detentions.
Next Steps
After Imports & Shipments, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your United States Opportunity?
Whether you are planning your first medical device shipment to the United States or optimizing an existing import operation, Taevas Global delivers the regulatory intelligence, customs strategy, and market entry expertise to get your device to U.S. customers faster and with full compliance confidence.
FDA CDRH pathway analysis tailored to your specific device class and intended use
HTS classification validation and landed cost modeling to optimize your import economics
Labeling and UDI compliance audit to prevent port-of-entry refusals before they happen
U.S. distributor identification and commercial entry strategy to accelerate revenue after clearance